Extracellular Hsp90 Binds to and Aligns Collagen-1 to Enhance Breast Cancer Cell Invasiveness

Author:

Singh Pragya1,Ramanathan Varshini2ORCID,Zhang Yang2ORCID,Georgakoudi Irene12,Jay Daniel G.1

Affiliation:

1. Department of Developmental, Molecular and Chemical Biology, Graduate School of Biomedical Sciences, Tufts University School of Medicine, Boston, MA 02111, USA

2. Department of Biomedical Engineering, Tufts University School of Engineering, Medford, MA 02155, USA

Abstract

Cancer cell-secreted eHsp90 binds and activates proteins in the tumor microenvironment crucial in cancer invasion. Therefore, targeting eHsp90 could inhibit invasion, preventing metastasis—the leading cause of cancer-related mortality. Previous eHsp90 studies have solely focused on its role in cancer invasion through the 2D basement membrane (BM), a form of extracellular matrix (ECM) that lines the epithelial compartment. However, its role in cancer invasion through the 3D Interstitial Matrix (IM), an ECM beyond the BM, remains unexplored. Using a Collagen-1 binding assay and second harmonic generation (SHG) imaging, we demonstrate that eHsp90 directly binds and aligns Collagen-1 fibers, the primary component of IM. Furthermore, we show that eHsp90 enhances Collagen-1 invasion of breast cancer cells in the Transwell assay. Using Hsp90 conformation mutants and inhibitors, we established that the Hsp90 dimer binds to Collagen-1 via its N-domain. We also demonstrated that while Collagen-1 binding and alignment are not influenced by Hsp90’s ATPase activity attributed to the N-domain, its open conformation is crucial for increasing Collagen-1 alignment and promoting breast cancer cell invasion. These findings unveil a novel role for eHsp90 in invasion through the IM and offer valuable mechanistic insights into potential therapeutic approaches for inhibiting Hsp90 to suppress invasion and metastasis.

Funder

NIH Research Grant program

National Institute of Biomedical Imaging and Bioengineering

National Institute of Health, the Office of the Director

National Cancer Institute

Publisher

MDPI AG

Subject

Cancer Research,Oncology

Reference98 articles.

1. Howlader, N., Noone, A.M., Krapcho, M., Miller, D., Brest, A., Yu, M., Ruhl, J., Tatalovich, Z., Mariotto, A., and Lewis, D.R. (2023, April 01). SEER Cancer Statistics Review (CSR) 1975–2018, Available online: https://seer.cancer.gov/csr/1975_2018/.

2. Macdonald, S., Oncology, R., and General, M. (2022). Breast Cancer Facts & Figures 2022–2024. Am. Cancer Soc.

3. Functional proteomic screens reveal an essential extracellular role for hsp90 alpha in cancer cell invasiveness;Eustace;Nat. Cell Biol.,2004

4. Devarakonda, C.V., Kita, D., Phoenix, K.N., and Claffey, K.P. (2015). Patient-derived heavy chain antibody targets cell surface HSP90 on breast tumors. BMC Cancer, 15.

5. High HSP90 expression is associated with decreased survival in breast cancer;Pick;Cancer Res.,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3